Follow
Scott Bell
Scott Bell
Unknown affiliation
Verified email at health.qld.gov.au
Title
Cited by
Cited by
Year
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ...
New England Journal of Medicine 365 (18), 1663-1672, 2011
24322011
The future of cystic fibrosis care: a global perspective
SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ...
The Lancet Respiratory Medicine 8 (1), 65-124, 2020
8352020
European cystic fibrosis society standards of care: best practice guidelines
AR Smyth, SC Bell, S Bojcin, M Bryon, A Duff, P Flume, N Kashirskaya, ...
Journal of cystic fibrosis 13, S23-S42, 2014
7742014
ECFS best practice guidelines: the 2018 revision
C Castellani, AJA Duff, SC Bell, HGM Heijerman, A Munck, F Ratjen, ...
Journal of cystic fibrosis 17 (2), 153-178, 2018
7642018
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
J Wolter, S Seeney, S Bell, S Bowler, P Masel, J McCormack
Thorax 57 (3), 212-216, 2002
6612002
Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals
DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ...
Annals of the American Thoracic Society 16 (1), 22-28, 2019
6292019
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ...
Science 354 (6313), 751-757, 2016
5422016
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised …
MP Boyle, SC Bell, MW Konstan, SA McColley, SM Rowe, E Rietschel, ...
The lancet Respiratory medicine 2 (7), 527-538, 2014
5252014
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ...
Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999
3851999
Genetic modifiers of liver disease in cystic fibrosis
JR Bartlett, KJ Friedman, SC Ling, RG Pace, SC Bell, B Bourke, ...
Jama 302 (10), 1076-1083, 2009
3422009
The rise of non-tuberculosis mycobacterial lung disease
CN Ratnatunga, VP Lutzky, A Kupz, DL Doolan, DW Reid, M Field, ...
Frontiers in immunology 11, 303, 2020
3382020
Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand
AB Chang, SC Bell, CA Byrnes, K Grimwood, PW Holmes, PT King, ...
Medical Journal of Australia 193, 356-365, 2010
322*2010
Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions
D Hill, B Rose, A Pajkos, M Robinson, P Bye, S Bell, M Elkins, ...
Journal of clinical microbiology 43 (10), 5085-5090, 2005
2802005
Neutrophils in cystic fibrosis
DG Downey, SC Bell, JS Elborn
Thorax 64 (1), 81-88, 2009
2732009
New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls
SC Bell, K De Boeck, MD Amaral
Pharmacology & therapeutics 145, 19-34, 2015
2432015
Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical …
SD Aaron, KL Vandemheen, W Ferris, D Fergusson, E Tullis, D Haase, ...
The Lancet 366 (9484), 463-471, 2005
2332005
Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals
DE Leisman, MO Harhay, DJ Lederer, M Abramson, AA Adjei, J Bakker, ...
Critical care medicine 48 (5), 623-633, 2020
2212020
Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study
HM Buntain, RM Greer, PJ Schluter, JCH Wong, JA Batch, JM Potter, ...
Thorax 59 (2), 149-155, 2004
1912004
Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON®‐CMV
S Walker, C Fazou, T Crough, R Holdsworth, P Kiely, M Veale, S Bell, ...
Transplant Infectious Disease 9 (2), 165-170, 2007
1892007
Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources
B De Smet, M Mayo, C Peeters, JEA Zlosnik, T Spilker, TJ Hird, JJ LiPuma, ...
International Journal of Systematic and Evolutionary Microbiology 65 (Pt_7 …, 2015
1832015
The system can't perform the operation now. Try again later.
Articles 1–20